Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated β-catenin degradation in gastric cancer

Fig. 6

SOP enhances the effects of cisplatin in gastric cancer cells. a AGS cells and b SGC7901 cells were treated with 10 μM cisplatin alone or in combination with 3 μM SOP for indicated days and CCK-8 assay was used to determine cellular cytotoxicity. c colony formulation in AGS and SGC7901 cells treated with 10 μM cisplatin alone or in combination with 3 μM SOP were visualized by crystal violet staining. d Statistical analysis of colony numbers in AGS and SGC7901 cells. e-g Apoptosis in AGS and SGC7901 cells treated with 10 μM cisplatin alone or in combination with 3 μM SOP were determined by flowcytometry. Abbreviation: SOP, Sophoridine. The results are representatives of at least 3 independent experiments. Data were presented as mean ± SD. **P < 0.01; ***P < 0.0001; NS, no significant difference. Abbreviation: SOP, Sophoridine

Back to article page